what is gip and glp-1 GLP‐1, the two incretin hormones: Similarities and differences A pathophysiological update of the

Skin-Pulling Disorder Symptoms People with skin-pulling disorder may see skin imperfections that others dont consider flaws

10.3390/nu12092645 62

The STEP 1 trial for semaglutide 2.4mg demonstrated a mean body weight reduction of approximately 14.9% over 68 weeks in adults with obesity. The SURMOUNT-1 trial for tirzepatide showed reductions of up to 22.5% at the highest dose. These are outcomes that approach the efficacy of bariatric surgery in some patient cohorts

The Great (Oral) GLP-1 Scare Why the Stevanato narrative is flawed This is not something that should take you by surprise because Ive talked about it in the past, but Stevanatos stock has been weak lately (maybe an understatement): This has happened despite the company (imho) receiving incrementally positive news over the past few months